227 related articles for article (PubMed ID: 27177606)
1. Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells.
Bordonaro M; Lazarova DL
JMIR Res Protoc; 2016 May; 5(2):e66. PubMed ID: 27177606
[TBL] [Abstract][Full Text] [Related]
2. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
Bordonaro M; Lazarova DL
World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
[TBL] [Abstract][Full Text] [Related]
3. Hypothesis: Sam68 and Pygo2 mediate cell type-specific effects of the modulation of CBP-Wnt and p300-Wnt activities in Colorectal Cancer Cells.
Bordonaro M
J Cancer; 2021; 12(16):5046-5052. PubMed ID: 34234873
[TBL] [Abstract][Full Text] [Related]
4. CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells.
Lazarova DL; Chiaro C; Wong T; Drago E; Rainey A; O'Malley S; Bordonaro M
J Cancer; 2013; 4(6):481-90. PubMed ID: 23901348
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Wnt Activity and Cell Physiology by Butyrate in LT97 Microadenoma Cells.
Lazarova D; Lee A; Wong T; Marian B; Chiaro C; Rainey C; Bordonaro M
J Cancer; 2014; 5(3):203-13. PubMed ID: 24563675
[TBL] [Abstract][Full Text] [Related]
6. p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells.
Lazarova DL; Wong T; Chiaro C; Drago E; Bordonaro M
J Cancer; 2013; 4(6):491-501. PubMed ID: 23901349
[TBL] [Abstract][Full Text] [Related]
7. ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
Lazarova D; Bordonaro M
J Cancer; 2017; 8(8):1453-1459. PubMed ID: 28638460
[TBL] [Abstract][Full Text] [Related]
8. Further analysis of p300 in mediating effects of Butyrate in Colorectal Cancer Cells.
Bordonaro M
J Cancer; 2020; 11(20):5861-5866. PubMed ID: 32922528
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic and Receptor-Mediated Wnt Signaling Influence the Sensitivity of Colonic Cells to Butyrate.
Bordonaro M
J Cancer; 2023; 14(3):446-453. PubMed ID: 36860917
[TBL] [Abstract][Full Text] [Related]
10. Altering cancer transcriptomes using epigenomic inhibitors.
Gaddis M; Gerrard D; Frietze S; Farnham PJ
Epigenetics Chromatin; 2015; 8():9. PubMed ID: 26191083
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM
Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
13. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.
Labalette C; Renard CA; Neuveut C; Buendia MA; Wei Y
Mol Cell Biol; 2004 Dec; 24(24):10689-702. PubMed ID: 15572674
[TBL] [Abstract][Full Text] [Related]
14. Involvement of activator protein-1 family members in β-catenin and p300 association on the genome of PANC-1 cells.
Doi T; Hojo H; Ohba S; Obayashi K; Endo M; Ishizaki T; Katoh A; Kouji H
Heliyon; 2022 Feb; 8(2):e08890. PubMed ID: 35198763
[TBL] [Abstract][Full Text] [Related]
15. p300/β-Catenin Interactions Regulate Adult Progenitor Cell Differentiation Downstream of WNT5a/Protein Kinase C (PKC).
Rieger ME; Zhou B; Solomon N; Sunohara M; Li C; Nguyen C; Liu Y; Pan JH; Minoo P; Crandall ED; Brody SL; Kahn M; Borok Z
J Biol Chem; 2016 Mar; 291(12):6569-82. PubMed ID: 26833564
[TBL] [Abstract][Full Text] [Related]
16. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
17. The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors.
Bordonaro M; Lazarova DL; Sartorelli AC
Exp Cell Res; 2007 May; 313(8):1652-66. PubMed ID: 17359971
[TBL] [Abstract][Full Text] [Related]
18. CBP/p300 are bimodal regulators of Wnt signaling.
Li J; Sutter C; Parker DS; Blauwkamp T; Fang M; Cadigan KM
EMBO J; 2007 May; 26(9):2284-94. PubMed ID: 17410209
[TBL] [Abstract][Full Text] [Related]
19. Wnt/β-catenin-dependent acetylation of Pygo2 by CBP/p300 histone acetyltransferase family members.
Andrews PG; Kao KR
Biochem J; 2016 Nov; 473(22):4193-4203. PubMed ID: 27647933
[TBL] [Abstract][Full Text] [Related]
20. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.
Ma H; Nguyen C; Lee KS; Kahn M
Oncogene; 2005 May; 24(22):3619-31. PubMed ID: 15782138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]